Summary
Pfizer Inc. filed an 8-K report on December 14, 1999, to disclose the publication of an advertisement on December 8, 1999, regarding its proposed merger with Warner-Lambert Company. This advertisement, which appeared in major financial publications like The New York Times and The Wall Street Journal, is incorporated by reference as an exhibit to this filing. Investors should note that this filing primarily serves to formally document the dissemination of information related to the significant proposed merger. While the 8-K itself does not provide new financial data or operational updates, the advertisement discussed is a key piece of communication regarding a major strategic event for Pfizer at the time. The report also includes a standard cautionary statement about forward-looking statements, reminding investors of the inherent risks and uncertainties associated with such statements and advising them to consult other SEC filings for a comprehensive understanding of potential risk factors.
Key Highlights
- 1Pfizer Inc. filed an 8-K on December 14, 1999.
- 2The filing references an advertisement published on December 8, 1999.
- 3The advertisement discusses Pfizer's proposed merger with Warner-Lambert Company.
- 4The advertisement was published in major news outlets including The New York Times and The Wall Street Journal.
- 5The advertisement is incorporated as Exhibit 99.1 to the 8-K filing.
- 6The report includes a disclaimer regarding forward-looking statements and associated risks.